Agenda

logos agenda

CLINICAL AND EPIDEMIOLOGY
Dr. Martín Castellanos Joya

Director. Mycobacteriosis Program
Secretaria de Salud, México
“Situación actual de la tuberculosis en México”

Dr. Luis Alejandro Pulido Espinosa

Chief. Mycobacteriosis Program in Ensenada Jurisdiction, Secretaria de Salud, México
“Tuberculosis Epidemiology in the border US-Mexico”

Dr. Rafael Laniado Laborín

Chief. Tuberculosis Clinic. General Hospital, Tijuana, Secretaria de Salud. Mexico
“Unstopable progression of drug resistant tuberculosis: from MDR to XDR to TDR”

Kathleen Moser, MD, MPH

Director. TB Control Program
San Diego County Health and Human Services Agency. USA
“Current diagnostic and genotyping tests used by US TB programs”.

Dr. Rafael Laniado Laborín

Chief. Tuberculosis Clinic. General Hospital, Tijuana, Secretaria de Salud. Mexico
“Diagnostic algorithms for tuberculosis in Latin America”

Dr. Roberto Zenteno Cuevas

Institute of Public Health, Universidad Veracruzana, Mexico.
“Type 2 diabetes mellitus and its influence in the development of drug resistant tuberculosis in Mexican population”

Richard S. Garfein, PhD, M.P.H

Professor. Division of Public Health Department of Medicine, University of California San Diego, USA
“Adherence to tuberculosis treatment”

Dr. Shin, Sanghyuk

Professor. Department of Epidemiology, University of California Los Angeles, USA
“Epidemiology of mixed-­‐strain Mycobacterium tuberculosis infections in a high HIV-­prevalent country”

Dr. Musharaf Tarajia Asvat

Research. INDICASAT-­‐AIP, Panamá
“Validation Process and introduction of a biomarker to clinical practice for the pleural TB in Central America: the Panamanian”

Dr. Octavio Villalobos

FronterasUnidas Pro Salud, A.C.
“Diabetes-­‐Tuberculosis”

MOLECULAR EVOLUTION
Dr. Philip Supply

Biology Institute of Lille, France
“Whole genome sequencing-based approaches to the origin and spread of tuberculosis”

Dr. Iñaki Comas

FISABIO-Public Health
Valencia, Spain
“Next generation sequencing to understand the epidemiology and evolution of the tuberculosis bacillus”

M. Sc. Diana Angélica Aguilar-Ayala

Instituto Politécnico Nacional, México / Ghent University, Belgium
“Transcriptomic analysis of Mycobacterium tuberculosis through Next Generation Sequencing: Insight into the active and dormant stage and the influence of lipids in its environment”

Dr. Roberto Zenteno Cuevas

Institute of Public Health, Universidad Veracruzana, Mexico.
“Molecular mechanisms of drug resistance in Tuberculosis”

IMMUNOLOGY AND VACCINATION
Dr. Rogelio Hernández Pando

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México.
“The effect of BCG vaccination on the virulence of M. tuberculosis”

Dr. Alejandro Escobar Gutiérrez

Instituto de Diagnóstico y Referencia Epidemiológicos. México
“Immunology of Tuberculosis”

Dr. Oscar Rojas-Espinosa

National School of Biological Sciences, Instituto Politécnico Nacional
“Neutrophils, NETs and Mycobacterium tuberculosis”

BOVINE TUBERCULOSIS
Dra. Suelee Robbe

APHIS-USDA, USA
“Mycobacterium bovis Whole Genome Sequencing SNP Analysis”

Dr. Gilberto López Valencia

Universidad Autónoma de Baja California, Mexico
“BCG vaccine for bovine tuberculosis prevention”

Dr. Alejandro Perera

APHIS-USDA México
“Bovine tuberculosis, human interface”